Skip to main content
Patrick Hu, MD, Oncology, Nashville, TN, Vanderbilt University Medical Center

PatrickJHuMDPhD

Oncology Nashville, TN

Gastrointestinal Cancer, Hematologic Oncology

Associate Professor of Medicine, Cell and Developmental Biology, and Cancer Biology, Vanderbilt University School of Medicine

Dr. Hu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hu's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General Hospital1999 - 2005
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
  • New York University School of Medicine
    New York University School of MedicineClass of 1995
  • Harvard University
    Harvard UniversityA.B., Biology, cum laude, 1981 - 1985

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2016 - 2025
  • MI State Medical License
    MI State Medical License 2005 - 2018
  • MA State Medical License
    MA State Medical License 1998 - 2007
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 2011

Publications & Presentations

PubMed

Journal Articles

  • Insulin/insulin-like growth factor signaling in C. elegans  
    Murphy CT, Hu PJ, Wormbook

Press Mentions

  • A Common Insulin Signaling Pathway Across Cancer and Diabetes
    A Common Insulin Signaling Pathway Across Cancer and DiabetesDecember 4th, 2019

Grant Support

  • FoxO Phosphorylation in the Control of C. elegans Life SpanNational Institute on Aging2012–Present
  • EAK-7, a Novel Regulator of FoxO Tumor SuppressorsAmerican Cancer Society2010–Present
  • Genetic Modifiers of In Vivo Hypoxia ResistanceAmerican Heart Association2011–2012
  • Novel Regulators Of FOXO Transcription FactorsNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
  • Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2004

Professional Memberships

  • American Society of Clinical Investigation
    Member
  • Genetics Society of America
    Member

Hospital Affiliations